Upjohn's minoxidil
Executive Summary
FDA's Dermatologic Drugs Advisory Committee will meet March 16 to review the use of Rogaine (minoxidil) in male pattern baldness. The committee was originally scheduled to meet Jan. 26, but a snow storm in the Washington, D.C. area forced postponement of the meeting.